Get the Stockscreener App
40.31
1.66%
-0.68
Astrana Health Inc stock is traded at $40.31, with a volume of 441.59K.
It is down -1.66% in the last 24 hours and down -4.64% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$40.99
Open:
$40.89
24h Volume:
441.59K
Relative Volume:
0.75
Market Cap:
$2.00B
Revenue:
$3.53B
Net Income/Loss:
$30.99M
P/E Ratio:
65.72
EPS:
0.6134
Net Cash Flow:
$154.99M
1W Performance:
-10.30%
1M Performance:
-4.64%
6M Performance:
+48.42%
1Y Performance:
+79.20%
1-Day Range:
$40.15
$42.14
1-Week Range:
$38.95
$45.80
52-Week Range:
$18.08
$51.60
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
40.31 | 2.00B | 3.53B | 30.99M | 154.99M | 0.6134 |
HCA
Hca Healthcare Inc
|
382.19 | 84.78B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
233.20 | 20.09B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
235.44 | 15.11B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.59 | 13.21B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
112.89 | 11.20B | 6.07B | 793.80M | 464.40M | 5.9914 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Needham | Buy |
| Apr-01-25 | Initiated | Barclays | Equal Weight |
| Oct-14-24 | Initiated | TD Cowen | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-11-24 | Upgrade | Truist | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Feb-26-24 | Initiated | Jefferies | Buy |
| Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-24 | Initiated | Stifel | Buy |
| Dec-22-23 | Initiated | Truist | Hold |
| Oct-17-23 | Initiated | BTIG Research | Buy |
| Apr-12-23 | Initiated | BofA Securities | Neutral |
| Dec-19-22 | Initiated | Lake Street | Buy |
| Sep-21-22 | Initiated | William Blair | Outperform |
| Jan-11-22 | Resumed | Colliers Securities | Buy |
| Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Can Astrana Health’s (ASTH) New Leadership Hires Clarify Its Value-Based Care Integration Strategy? - simplywall.st
Astrana Health Drops 7.9% Amid Sector-Wide Selling - AlphaStreet
Astrana Health Inc (ASTH) Shares Fall 7.7% -- What GF Score of 8 - GuruFocus
Astrana Health Inc (ASTH) Shares Fall 7.7% -- What GF Score of 85 Tells Investors - GuruFocus
Astrana Health (ASTH) Could Be 4% Below Fair Value As New Leaders Take Key Roles - Sahm
ASTH Stock Price, Quote & Chart - ChartMill
Astrana Health (ASTH) The 44th Annual William Blair Growth Stock Conference Summary - Quartr
Astrana Health, Inc. (ASTH) surges 7.3%: Is this an indication of further gains? - MSN
BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $65 - Moomoo
Astrana Health (ASTH) Stock Looks Fully Valued Following Its 87% Run - Yahoo Finance
Astrana Health Inc (ASTH) Stock Down 4.0% -- Now Undervalued? GF Score: 87/100 - GuruFocus
BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $65 - Moomoo
Astrana Health (ASTH) Q4 2024 earnings summary - Quartr
Why Astrana Health Is Dropping 5.6%: TD Cowen Maintains Buy - AlphaStreet
2 Reasons to Like ASTH and 1 to Stay Skeptical - Yahoo Finance
Astrana Health (ASTH) Bank of America Global Healthcare Conference 2026 Summary - Quartr
Astrana Health to announce Q2FY26 results on August 6 - scanx.trade
Astrana Health Schedules Aug. 6 Call on Second-Quarter Results - Stock Titan
ASTH Maintained by TD Cowen -- Price Target Raised to $50.00 - GuruFocus
US-based Astrana Health’s ACOs generate USD 120.4M in gross shared savings - Medical Buyer
Astrana Health names executives for physician enterprise, transformation - Investing.com
Astrana Health names executives for physician enterprise, transformation By Investing.com - Investing.com Canada
Press Release: Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth - Moomoo
Astrana Health Reports Strong Medicare ACO Shared Savings Performance - TipRanks
Astrana Health (NASDAQ: ASTH) posts $120.4M ACO savings and $3.18B 2025 revenue - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year - PR Newswire
New Astrana Health leaders tasked with scaling its AI-enabled care platform - Stock Titan
Price to earnings forward of Astrana Health Inc. – DUS:3AM - TradingView
Enterprise value to revenue forward of Astrana Health Inc. – DUS:3AM - TradingView
Astrana Health (ASTH) Stock Trades At A Premium On Earnings But Strong On Returns - simplywall.st
Is Astrana Health’s (ASTH) CFO Transition Quietly Reframing Its Value-Based Care Risk Profile? - simplywall.st
Astrana Health earnings ahead: Can value-based model sustain growth? - Investing.com
ASTH Technical Analysis & Stock Price Forecast - Intellectia AI
Astrana Health (NASDAQ:ASTH) Screens as a Powerful Minervini Trend Template Stock with High Growth Momentum - ChartMill
Astrana Health, Inc. (ASTH) Surges 7.3%: Is This an Indication of Further Gains? - Yahoo Finance
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
Astrana Health Chief Accounting Officer to Retire - Moomoo
Astrana Health Q1 2026 Earnings: EPS Misses Estimates, Yet Shares Rally 7.33%Estimate Dispersion - dars.gov.et
Astrana Health, Inc. Files SEC Form 8-K: Key Details on NASDAQ-Listed ASTH Stock and Company Information - Minichart
Astrana Health announces planned accounting leadership transition - TipRanks
Astrana Health (NASDAQ: ASTH) taps John Vong as new accounting head - Stock Titan
Astrana Health Jumps 7.1% Amid Sector-Wide Rally - AlphaStreet
A Look at Astrana Health Inc (ASTH) After 3.1% Gain -- GF Value $82.34 vs Price $46.41 - GuruFocus
Form 4 Astrana Health Inc For: 30 June By Investing.com - Investing.com Nigeria
Astrana Health (ASTH) CEO Brandon Sim logs tax-withholding share disposition and updated holdings - Stock Titan
Astrana Health stock hits 52-week high at 45.11 USD - Investing.com
Astrana Health stock hits 52-week high at 45.11 USD By Investing.com - Investing.com Nigeria
Jefferies Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $53 - Moomoo
Astrana Health, Inc. Hits New 52-Week High of USD 41.23 - MarketsMojo
Astrana Health Inc. Actuals & Estimates (NASDAQ:ASTH) - TradingView
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Astrana Health Inc Stock (ASTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
| Kitayama Mitchell W | Director |
Sep 15 '25 |
Option Exercise |
18.20 |
8,000 |
145,600 |
29,060 |
| Schmidt David | Director |
Sep 02 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
35,763 |
| Chiang John | Director |
Aug 13 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
43,132 |
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):